Clinical Trial Update: Study of How Safe and Effective Tarlatamab is in Brain Cancers [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the safety and effectiveness of tarlatamab in brain cancers is currently recruiting. The study targets astrocytoma and oligode…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Astrocytoma
• Oligodendroglioma

Drugs mentioned

• Tarlatamab

Snippet

Sponsor: University Health Network, Toronto | Conditions: Astrocytic Tumor, Oligodendroglial Tumor | Phase 2 | Status: RECRUITING